Neurovirulence for mice of soluble receptor-resistant mutants of murine coronavirus JHMV.
Matsuyama
S
S
National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.
Watanabe
R
R
Taguchi
F
F
D000818:Animals; D001921:Brain / Q000473:pathology / Q000821:virology; D015815:Cell Adhesion Molecules; D002493:Central Nervous System Diseases / Q000473:pathology / Q000503:physiopathology* / Q000821:virology; D018352:Coronavirus Infections / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D006023:Glycoproteins / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR; D006517:Murine hepatitis virus / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D009154:Mutation; D064370:Spike Glycoprotein, Coronavirus; D013116:Spinal Cord / Q000473:pathology / Q000821:virology; D014759:Viral Envelope Proteins / Q000235:genetics* / Q000378:metabolism; D014774:Virulence
C087701:Ceacam2 protein, mouse; D015815:Cell Adhesion Molecules; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D064370:Spike Glycoprotein, Coronavirus; D014759:Viral Envelope Proteins